TREAT Asia News
-
Improving Transgender Health in Southeast Asia
A new study seeks to improve HIV-related transgender health in Thailand, Vietnam, and the Philippines.
-
HIV Care Continuum & Beyond: A New Era for Asia
With TREAT Asia as one of its partners, an initiative strives to strengthen HIV policies and programs across a regional cascade of care.
-
Dangerous Inequalities
New UNAIDS report identifies key drivers of the HIV epidemic: gender inequalities, discrimination against key populations, and failures to address needs of children with HIV.
-
TREAT Asia Calls for Expanded Access to Pediatric Dolutegravir
Facilitating access to formulations of the HIV medicine dolutegravir (DTG) that can be used by infants and children living with HIV in the Asia-Pacific is an urgent concern. In light of recent U.S. and European regulatory approvals of a dispersible version of pediatric DTG, amfAR’s TREAT Asia program recommends steps that national HIV programs and…
-
Recent ARV Stockouts in India Created a Health Crisis for People Living with HIV
An antiretroviral therapy stockout in India limited treatment options and created barriers to healthcare access for people living with HIV.
-
UNAIDS: Most New HIV Infections Among Children Are Preventable
UNAIDS estimates that most of the 150,000 new HIV infections among children in 2020 could have been prevented.
-
COVID-19 Pandemic Threatens HIV Drug Supplies
There is mounting concern in many countries, and emerging acutely in Asia, about a growing shortage of lifesaving antiretroviral drugs as a result of supply chain disruptions and stock-outs caused by the COVID-19 pandemic. Experts fear that further disruptions could halt and even reverse the hard-won progress on HIV/AIDS that has been achieved in many…
-
amfAR’s TREAT Asia program contributes to success of multi-year collaboration on treatment access
More than 58 million people worldwide are living with chronic hepatitis C virus (HCV) infection, according to the World Health Organization. In 2019, an estimated 290,000 people died from diseases such as cirrhosis or liver cancer as a consequence of HCV.
-
Tracking COVID-19’s Impact and Vaccine Uptake in the Asia-Pacific Region
TREAT Asia program launches new website with up-to-date data across graphs, tables, and maps charting the impact of COVID-19 in the region.
-
TREAT Asia Mourns the Passing of Cambodian Network Investigator Dr. Ly Penh Sun
With the passing of Dr. Ly Penh Sun on November 9, 2021, we lost a regional champion for HIV prevention, care, and research.
-
New Pediatric HIV Site in Indonesia Joins TREAT Asia Research Network
TREAT Asia has added a new site to their pediatric HIV research program with the Kirby Institute, as part of the US NIH-funded International Epidemiology Databases to Evaluate AIDS (IeDEA) Asia-Pacific network.
-
NIH Award Reaffirms TREAT Asia’s Collaborative Leadership on HIV/AIDS in the Asia-Pacific
For 20 years, amfAR’s TREAT Asia program has been working with partners across the region to expand access to treatment for HIV and related conditions such as hepatitis C and improve standards of care.
-
A Forgotten Epidemic: Expanding Treatment Access for Hepatitis C
Despite the existence of direct-acting antivirals (DAAs) that can cure more than 95% of people with HCV, these drugs remain difficult to access for those who need them.
-
Getting PrEP to Key Populations Is Critical to Global Fight Against HIV
Key populations and their partners account for 50% or more of global HIV infections—80% of new HIV infections outside of sub-Saharan Africa.
-
ViiV Healthcare and TREAT Asia Partner on Important New Study of Young Adults with HIV
There are more than five million adolescents and young adults living with HIV worldwide, many of whom acquired the virus as infants and must navigate the complex transition from pediatric to adult care. The study of pediatric and adolescent HIV has long been a focus of amfAR’s TREAT Asia program, whose pediatric HIV database, launched…